R. Josien et al., FAS LIGAND, TUMOR-NECROSIS-FACTOR-ALPHA EXPRESSION, AND APOPTOSIS DURING ALLOGRAFT-REJECTION AND TOLERANCE, Transplantation, 66(7), 1998, pp. 887-893
Background. Cytotoxic T cells can induce target cell lysis and apoptos
is by different pathways. The interactions of CD95 antigen (Fas) with
its ligand (CD95L) and of tumor necrosis factor (TNF)-alpha with its r
eceptor (TNF-R1) lead to apoptotic cell death. Recently, conflicting s
tudies have been published concerning the expression and the role of C
D95L in allograft rejection and tolerance. Methods. In this study, the
intragraft expression of CD95/CD95L and TNF-alpha and the frequency a
nd distribution of apoptotic cells were compared in a model of heterot
opic cardiac allograft in the rat in which recipients were either not
treated (acute rejection) or pretreated with donor-specific blood tran
sfusion (tolerant). Results. in the acutely rejected allografts, a pea
k in the expression of CD95L and TNF-alpha and in the number of apopto
tic cells was observed during the first week after transplantation; ap
optotic cells were confined to graft-infiltrating cells. In the tolera
ted allografts, how ever, levels of graft-infiltrating cell apoptosis
and CD95L and TNF-alpha expression during the same period of time were
dramatically lower. The expression of Fas was constitutive and was no
t modulated during acute rejection or tolerance. Conclusion. This down
-regulation of CD95L and TNF-alpha in allografts rendered tolerant by
donor-specific transfusion suggests a role for apoptosis-inducing path
ways in acute allograft rejection.